NASDAQ · USD

Drugs Made In America Acquisition Corp. (DMAAR) Stock Analysis

Drugs Made In America Acquisition Corp. (DMAAR) is a stock listed on NASDAQ and quoted in US Dollar.

DMAAR

$0.13

$0.00 (0.00%)

Sep 4, 2026 · Market close

This is a derivative instrument — a right to Drugs Made In America Acquisition Corp. (DMAA) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View DMAA →

Price History

Hover for the daily close. The dotted line marks the period open.

DMAAR Key Statistics

As of Sep 4, 2026

Trading

Open: $0.13
Previous Close: $0.13
Day's Range: 0.12–0.13
52-Week Range: 0.12–0.13
Volume: 1.35K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

About Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.